In addition, Hela cells (cervical cancer) and DU-145 cells (prostatic cancer) also did not show enhanced migratory ability in high glucose level (data not shown), suggesting specificity of estrogen-receptor positive breast cancer cell for sensitivity in hyper glycemia as clinical statistical data. The gene discussed is ESR1; the disease is breast carcinoma.